Because both N- and IBD-derived CMFs expressed basal levels of PD-L2 and PD-L1, to determine the relative contribution of either ligand to the CMF-mediated suppression of Th1 immune response, experiments were included studies in which PD-L2 was silenced using specific siRNA. The gene discussed is PDCD1LG2; the disease is inflammatory bowel disease.